| Name | HCV-IN-36 |
|---|
| Description | HCV-IN-36 (compound (S)-3h) is an orally active and potent HCV entry inhibitor. HCV-IN-36 shows excellent antiviral activity, with an EC50 of 0.016 μM and a CC50 (half-maximal cytotoxic concentration) of 8.78 μM[1]. |
|---|---|
| Related Catalog | |
| Target |
EC50: 0.016 ± 0.007 μM (HCV)[1] |
| References |
| Molecular Formula | C30H36ClN5 |
|---|---|
| Molecular Weight | 502.09 |